Gene Electrotransfer in Clinical Trials

  • Julie Gehl
Part of the Methods in Molecular Biology book series (MIMB, volume 1121)


Electroporation is increasingly being used for delivery of chemotherapy to tumors. Likewise, gene delivery by electroporation is rapidly gaining momentum for both vaccination purposes and for delivery of genes coding for other therapeutic molecules, such as chronic diseases or cancer. This chapter describes how gene therapy may be performed using electric pulses to enhance uptake and expression.

Key words

Gene therapy Gene delivery Electrotransfer Electroporation Anesthesia Standard operating procedures 


  1. 1.
    Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH (1982) Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1:841–845PubMedGoogle Scholar
  2. 2.
    Rols MP, Delteil C, Golzio M, Dumond P, Cros S, Teissie J (1998) In vivo electrically mediated protein and gene transfer in murine melanoma. Nat Biotechnol 16:168–171PubMedCrossRefGoogle Scholar
  3. 3.
    Mir LM, Bureau MF, Gehl J et al (1999) High efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci U S A 96:4262–4267PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Flanagan M, Gimble JM, Yu G et al (2011) Competitive electroporation formulation for cell therapy. Cancer Gene Ther 18:579–586PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Hirao LA, Wu L, Khan AS, Satishchandran A, Draghia-Akli R, Weiner DB (2008) Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques. Vaccine 26:440–448PubMedCrossRefGoogle Scholar
  6. 6.
    Daud AI, DeConti RC, Andrews S et al (2008) Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 26:5896–5903PubMedCrossRefGoogle Scholar
  7. 7.
    Matthiessen LW, Chalmers RL, Sainsbury DC et al (2011) Management of cutaneous metastases using electrochemotherapy. Acta Oncol 50:621–629PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Mir LM, Gehl J, Sersa G et al (2006) Standard operating procedures of the electrochemotherapy: instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator (TM) by means of invasive or non-invasive electrodes. Eur J Cancer 4: 4–25Google Scholar
  9. 9.
    Andre F, Gehl J, Sersa G et al (2008) Efficiency of high and low voltage pulse combinations for gene electrotransfer in muscle, liver, tumor and skin. Hum Gene Ther 19:1261–1271PubMedCrossRefGoogle Scholar
  10. 10.
    Gothelf A, Eriksen J, Hojman P, Gehl J (2010) Duration and level of transgene expression after gene electrotransfer to skin in mice. Gene Ther 17:839–845PubMedCrossRefGoogle Scholar
  11. 11.
    Hargrave B, Downey H, Strange R et al (2013) Electroporation-mediated gene transfer directly to the swine heart. Gene Ther 20:151–157PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Marshall WG, Boone BA, Burgos JD et al (2010) Electroporation-mediated delivery of a naked DNA plasmid expressing VEGF to the porcine heart enhances protein expression. Gene Ther 17:419–423PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    O’Reilly MA, Yee M, Buczynski BW et al (2012) Neonatal oxygen increases sensitivity to influenza A virus infection in adult mice by suppressing epithelial expression of Ear1. Am J Pathol 181:441–451PubMedCrossRefGoogle Scholar
  14. 14.
    Agerholm-Larsen B, Iversen HK, Ibsen P et al (2011) Preclinical validation of electrochemotherapy as an effective treatment for brain tumors. Cancer Res 71:3753–3762PubMedCrossRefGoogle Scholar
  15. 15.
    Gothelf A, Gehl J (2010) Gene electrotransfer to skin; review of existing literature and clinical perspectives. Curr Gene Ther 10:287–299PubMedCrossRefGoogle Scholar
  16. 16.
    Gehl J, Sørensen TH, Nielsen K et al (1999) In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution. Biochim Biophys Acta 1428:233–240PubMedCrossRefGoogle Scholar
  17. 17.
    Spanggaard I, Snoj M, Cavalcanti A et al (2012) Proof of concept of gene therapy using plasmid AMEP in disseminated melanoma: safety and efficacy results of a phase I first-in-man study. Ann Oncol 23(Suppl 9):ixe20–ixe1139Google Scholar
  18. 18.
    Spanggaard I, Corydon T, Hojman P et al (2012) Spatial distribution of transgenic protein after gene electrotransfer to porcine muscle. Hum Gene Ther Meth 23: 387–392CrossRefGoogle Scholar
  19. 19.
    Hojman P, Spanggaard I, Olsen CH, Gehl J, Gissel H (2011) Calcium electrotransfer for termination of transgene expression in muscle. Hum Gene Ther 22:753–760PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Julie Gehl
    • 1
  1. 1.Department of Oncology, Center for Experimental Drug and Gene ElectrotransferCopenhagen University HospitalHerlevDenmark

Personalised recommendations